Terms: = Germ cell tumor AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Diagnosis
46 results:
1. BRAF Mutated and Morphologically Spitzoid tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz Neoplasms.
Gerami P; Chen A; Sharma N; Patel P; Hagstrom M; Kancherla P; Geraminejad T; Olivares S; Biswas A; Bosenberg M; Busam KJ; de La Fouchardière A; Duncan LM; Elder DE; Ko J; Landman G; Lazar AJ; Lowe L; Massi D; Mihic-Probst D; Parker DC; Scolyer RA; Shea CR; Zembowicz A; Yun SJ; Blokx WAM; Barnhill RL
Am J Surg Pathol; 2024 May; 48(5):538-545. PubMed ID: 38525831
[TBL] [Abstract] [Full Text] [Related]
2. Spitz tumor with RAF1 fusion: A report of 3 cases.
Donati M; Nosek D; Olivares S; Lemahieu J; Loontiens S; Mansour B; Gerami P; Kazakov DV
Ann Diagn Pathol; 2023 Dec; 67():152215. PubMed ID: 37856952
[TBL] [Abstract] [Full Text] [Related]
3. Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic tumors With Activating Mutations in MAP2K1.
Fumero-Velázquez M; Hagstrom M; Dhillon S; Geraminejad T; Olivares S; Donati M; Nosek D; Waldenbäck P; Kazakov D; Sheffield BS; Tron VA; Gerami P
Am J Surg Pathol; 2023 Dec; 47(12):1438-1448. PubMed ID: 37773074
[TBL] [Abstract] [Full Text] [Related]
4. Agminated presentation of fusion-driven melanocytic neoplasms.
Fumero-Velázquez M; Hagstrom M; Dhillon S; Olivares S; Jennings LJ; Dittman D; Sukhanova M; Arva NC; Goldstein SD; Theos A; Pavlidakey P; Carr Z; Gerami P
J Cutan Pathol; 2023 Oct; 50(10):913-921. PubMed ID: 37407520
[TBL] [Abstract] [Full Text] [Related]
5. An update on genomic aberrations in Spitz naevi and tumours.
Hagstrom M; Fumero-Velázquez M; Dhillon S; Olivares S; Gerami P
Pathology; 2023 Mar; 55(2):196-205. PubMed ID: 36631338
[TBL] [Abstract] [Full Text] [Related]
6. Next-generation Sequencing as a Potential Diagnostic Adjunct in Distinguishing Between Desmoplastic Melanocytic Neoplasms.
Roth A; Boutko A; Lampley N; Dhillon S; Hagstrom M; Olivares S; Dittman D; Jennings L; Santana Dos Santos L; Busam K; Gerami P
Am J Surg Pathol; 2023 Mar; 47(3):318-325. PubMed ID: 36383901
[TBL] [Abstract] [Full Text] [Related]
7. Investigating the role of somatic sequencing platforms for phaeochromocytoma and paraganglioma in a large UK cohort.
Winzeler B; Tufton N; S Lim E; Challis BG; Park SM; Izatt L; Carroll PV; Velusamy A; Hulse T; Whitelaw BC; Martin E; Rodger F; Maranian M; Clark GR; A Akker S; Maher ER; Casey RT
Clin Endocrinol (Oxf); 2022 Oct; 97(4):448-459. PubMed ID: 34870338
[TBL] [Abstract] [Full Text] [Related]
8. Benign and Intermediate-grade Melanocytic tumors With BRAF Mutations and Spitzoid Morphology: A Subset of Melanocytic Neoplasms Distinct From Melanoma.
Zhao J; Benton S; Zhang B; Olivares S; Asadbeigi S; Busam K; Gerami P
Am J Surg Pathol; 2022 Apr; 46(4):476-485. PubMed ID: 34753863
[TBL] [Abstract] [Full Text] [Related]
9. Infrequent RAS mutation is not associated with specific histological phenotype in gliomas.
Makino Y; Arakawa Y; Yoshioka E; Shofuda T; Minamiguchi S; Kawauchi T; Tanji M; Kanematsu D; Nonaka M; Okita Y; Kodama Y; Mano M; Hirose T; Mineharu Y; Miyamoto S; Kanemura Y
BMC Cancer; 2021 Sep; 21(1):1025. PubMed ID: 34525976
[TBL] [Abstract] [Full Text] [Related]
10. Genetics of pheochromocytoma and paraganglioma.
Wachtel H; Fishbein L
Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):283-290. PubMed ID: 33764930
[TBL] [Abstract] [Full Text] [Related]
11. Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach.
Parra O; Lefferts JA; Tafe LJ; Gru AA; Linos K
Hum Pathol; 2021 Jun; 112():35-47. PubMed ID: 33636207
[TBL] [Abstract] [Full Text] [Related]
12. Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma.
Jiang J; Zhang J; Pang Y; Bechmann N; Li M; Monteagudo M; Calsina B; Gimenez-Roqueplo AP; Nölting S; Beuschlein F; Fassnacht M; Deutschbein T; Timmers HJLM; Åkerström T; Crona J; Quinkler M; Fliedner SMJ; Liu Y; Guo J; Li X; Guo W; Hou Y; Wang C; Zhang L; Xiao Q; Liu L; Gao X; Burnichon N; Robledo M; Eisenhofer G
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32750708
[TBL] [Abstract] [Full Text] [Related]
13. Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry.
Hurst Z; Liyanarachchi S; He H; Brock P; Sipos J; Nabhan F; Kebebew E; Green P; Cote GJ; Sherman S; Walker CJ; Chang YS; Xue S; Hollingsworth B; Li W; Genutis L; Menq E; de la Chapelle A; Jhiang SM
Thyroid; 2019 Apr; 29(4):530-539. PubMed ID: 30654714
[TBL] [Abstract] [Full Text] [Related]
14. Primary and secondary mucosal melanoma of the small intestine - a clinical, pathological, and genetic nationwide survey of Danish patients between 1980 and 2014.
Tingsgaard JK; Henriksen A; Mikkelsen LH; Behrendt N; Melchior LC; Svendsen LB; Heegaard S
APMIS; 2018 Sep; 126(9):739-745. PubMed ID: 30160023
[TBL] [Abstract] [Full Text] [Related]
15. Genetic and epigenetic differences of benign and malignant pheochromocytomas and paragangliomas (PPGLs).
Khatami F; Mohammadamoli M; Tavangar SM
Endocr Regul; 2018 Jan; 52(1):41-54. PubMed ID: 29453919
[TBL] [Abstract] [Full Text] [Related]
16. NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the hrasQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2.
Reagh J; Bullock M; Andrici J; Turchini J; Sioson L; Clarkson A; Watson N; Sheen A; Lim G; Delbridge L; Sidhu S; Sywak M; Aniss A; Shepherd P; Ng D; Oei P; Field M; Learoyd D; Robinson BG; Clifton-Bligh RJ; Gill AJ
Am J Surg Pathol; 2017 Jan; 41(1):75-81. PubMed ID: 27635947
[TBL] [Abstract] [Full Text] [Related]
17. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract] [Full Text] [Related]
18. A Calcitonin Non-producing Neuroendocrine tumor of the Thyroid Gland.
Kasajima A; Cameselle-Teijeiro J; Loidi L; Takahashi Y; Nakashima N; Sato S; Fujishima F; Watanabe M; Nakazawa T; Naganuma H; Kondo T; Kato R; Sasano H
Endocr Pathol; 2016 Dec; 27(4):325-331. PubMed ID: 26860935
[TBL] [Abstract] [Full Text] [Related]
19. Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus.
Chan MP; Andea AA; Harms PW; Durham AB; Patel RM; Wang M; Robichaud P; Fisher GJ; Johnson TM; Fullen DR
Mod Pathol; 2016 Mar; 29(3):227-39. PubMed ID: 26743478
[TBL] [Abstract] [Full Text] [Related]
20. Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes.
Wilzén A; Rehammar A; Muth A; Nilsson O; Tešan Tomić T; Wängberg B; Kristiansson E; Abel F
Int J Cancer; 2016 May; 138(9):2201-11. PubMed ID: 26650627
[TBL] [Abstract] [Full Text] [Related]
[Next]
